British American Tobacco (NYSE:BTI) is a leading global tobacco company known for its wide range of products, including cigarettes, tobacco, and nicotine products. The company operates in a highly competitive industry, with major competitors like Philip Morris International and Altria Group. BTI's financial performance and strategic decisions are closely watched by investors and analysts.
On August 1, 2025, BTI reported its earnings before the market opened. The company achieved an earnings per share (EPS) of $2.14, slightly below the estimated EPS of $2.19. Despite this, BTI remains optimistic about its future performance. The company reaffirmed its confidence in achieving the upper range of its 2025 revenue growth guidance, projected to be between 1% and 2% at constant rates, as highlighted by WSJ.
BTI's actual revenue for the period was approximately $15.97 billion, falling short of the estimated $16.22 billion. However, the company's valuation metrics provide a deeper understanding of its market position. With a price-to-earnings (P/E) ratio of 29.13, the market values BTI's earnings significantly. The price-to-sales ratio of 3.48 and enterprise value to sales ratio of 4.70 further reflect the company's market value relative to its sales.
The company's financial health is also evident in its cash flow efficiency. BTI's enterprise value to operating cash flow ratio is approximately 12.01, indicating how efficiently the company generates cash from its operations. Additionally, the earnings yield of 3.43% offers investors a perspective on the return on investment, being the inverse of the P/E ratio.
BTI's debt-to-equity ratio of 0.74 suggests a moderate level of debt relative to equity, indicating a balanced approach to financing. However, the current ratio of 0.76 highlights the company's ability to cover short-term liabilities with short-term assets, which is an important consideration for assessing liquidity.
